EUVIMEDEUVIMED entdecken
Crossref

An Immune Nanoenhancer Revitalizes Chemotherapeutics to Tailor Tumor‐Derived dsDNA for Anticancer Immunoengineering

Yiming Liu, Yachao Li, Wensheng Gong, Dongzhe Zou, Beiling Guo, Zenan Zeng, Xiaoxiao Li, Yini Xu, Xianghui Xu iD

Advanced Materials · 2026

DOI: 10.1002/adma.202516524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Yiming Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Peptide Biomedicine Laboratory (PBL), College of Biology, Hunan University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Immunotherapy, Antineoplastic Agents, DNA, Neoplasms. Die Arbeit nennt 60 Literaturangaben. Gefördert von: Young Talents of Hunan Province, Excellent Young Scientists Fund of Hunan Province, Xiangjiang Public Welfare Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy has revolutionized the landscape of cancer treatment; however, most current strategies target only isolated steps of the cancer‐immunity cycle and therefore struggle to achieve durable clinical success. Central to immune surveillance, the cGAS‐STING pathway orchestrates innate and adaptive responses by promoting dendritic cell maturation, cytotoxic T lymphocyte infiltration, and durable immunological memory. However, chemotherapeutic activation of this axis remains elusive due to a paucity of safe, efficacious, and translatable inducers of tumor‐derived double‐stranded DNA (dsDNA). Here, we report a rationally engineered immune nanoenhancer platform–C‐iNE/A, that reprograms approved chemotherapeutics to initiate robust dsDNA‐driven cGAS‐STING activation in tumors even at low drug doses. Guided by machine learning, we optimize chemotherapeutic encapsulation and combine it with photophysically triggered mild hyperthermia to impair DNA repair while sparing healthy tissues. This cascade promotes intratumoral dsDNA accumulation, immunogenic release, and sustained immune activation. C‐iNE/A elicited potent immune responses across tumor models, enhancing dendritic cell maturation, amplifying cytotoxic T lymphocyte infiltration, suppressing metastasis, and establishing memory T cell populations. Our approach establishes a generalizable strategy to convert conventional chemotherapeutics into immune activators at safe drug doses, offering a clinically relevant platform to overcome current limitations in STING‐based immunotherapy and advance the next generation of tumor‐immunomodulatory regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyAntineoplastic AgentsDNANeoplasmsAnimalsHumansMiceCell Line, TumorDendritic CellsT-Lymphocytes, CytotoxicMice, Inbred C57BLMembrane ProteinsNucleotidyltransferases

Stichwörter der Autor:innen

anticancer immunoengineeringcGAS‐STING activationimmune nanoenhancersmachine learning‐optimized chemotherapeuticssmart nanomaterialstumor‐derived dsDNA

Substanzen

Antineoplastic AgentsDNAMembrane ProteinsNucleotidyltransferases

Autor:innen und Institutionen

  • Peptide Biomedicine Laboratory (PBL), College of Biology, Hunan University, Changsha, Hunan, China.
  • State Key Laboratory of Chemo and Biosensing, Key Laboratory For Bio-Nanotechnology and Molecular Engineering of Hunan Province, Hunan Provincial Key Laboratory of Medical Virology, Hunan University, Changsha, Hunan, Ch…

ORCID-Profile: Xianghui Xu

Förderung

  • Young Talents of Hunan Province
  • Excellent Young Scientists Fund of Hunan Province
  • Xiangjiang Public Welfare Foundation of Hunan Province
  • National Natural Science Foundation of China
  • Key Research and Development Program of Hunan Province of China
  • Flexibly Recruited High-End Talent of Yunnan Province

Zitieren

APA

Liu, Y., Li, Y., Gong, W., Zou, D., Guo, B., Zeng, Z., Li, X., Xu, Y., & Xu, X. (2026). An Immune Nanoenhancer Revitalizes Chemotherapeutics to Tailor Tumor‐Derived dsDNA for Anticancer Immunoengineering. Advanced Materials. https://doi.org/10.1002/adma.202516524

Vancouver

Liu Y, Li Y, Gong W, Zou D, Guo B, Zeng Z, et al. An Immune Nanoenhancer Revitalizes Chemotherapeutics to Tailor Tumor‐Derived dsDNA for Anticancer Immunoengineering. Advanced Materials. 2026. doi:10.1002/adma.202516524

BibTeX
@article{Liu2026,
  author = {Liu, Yiming and Li, Yachao and Gong, Wensheng and Zou, Dongzhe and Guo, Beiling and Zeng, Zenan and Li, Xiaoxiao and Xu, Yini and Xu, Xianghui},
  title = {An Immune Nanoenhancer Revitalizes Chemotherapeutics to Tailor Tumor‐Derived dsDNA for Anticancer Immunoengineering},
  journal = {Advanced Materials},
  year = {2026},
  doi = {10.1002/adma.202516524}
}
Kostenlos starten →